At the heart of European Life Sciences, the Netherlands offers a longstanding tradition of biomedical research. In the Amsterdam Metropolitan Area, scientific excellence is empowered by metropolitan strengths, turning the region into a unique hotspot for life sciences. Sandra Migchielsen, Senior Project Manager / Cluster Manager for Life Sciences at Amsterdam Innovation Motor, hosting BIO-Europe Spring® in March 2012, illustrates how the region is building its niche as the Netherlands’ only BioMetropolitan Area.
In any major pharmaceutical operation there are hundreds of different functions, departments and teams. Trying to understand how it all fits together can be a nightmare. Just to make it more complicated there are also different ‘views’ of the organisation – functional hierarchy, therapy areas, project structures, and so on. John Faulkes, Key Associate from PPMLD describes how the pharma business fits together.
FlandersBio is the umbrella organization for the life sciences and biotechnology sector in Flanders. This network brings together companies with innovative, R&D-driven activities in the life sciences sectors. Joke Comijn, Communications Manager at FlandersBio, provides an overview of Knowledge for Growth and an insight into Europe’s largest regional biotech convention.
With the arrival of every dramatically new technology, patent law must evolve to keep up. When stem cell research first emerged, the law was not clear as to whether the fruits of this research could be patented. Jenny Donald, Senior Associate and Charlotte Teall, Associate in Biotechnology at Forresters discuss how the Court of Justice of the European Union (CJEU) handed down a landmark judgement which overrides all pre-existing national law on stem cell patentability in Europe